These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 18496794)

  • 1. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond rhodopsin: G protein-coupled receptor structure and modeling incorporating the beta2-adrenergic and adenosine A(2A) crystal structures.
    Tebben AJ; Schnur DM
    Methods Mol Biol; 2011; 672():359-86. PubMed ID: 20838977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine receptor modelling. A1/A2a selectivity.
    Tuccinardi T; Ortore G; Manera C; Saccomanni G; Martinelli A
    Eur J Med Chem; 2006 Mar; 41(3):321-9. PubMed ID: 16427161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site.
    Wolf S; Böckmann M; Höweler U; Schlitter J; Gerwert K
    FEBS Lett; 2008 Oct; 582(23-24):3335-42. PubMed ID: 18775703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
    Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
    Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.
    Sherbiny FF; Schiedel AC; Maass A; Müller CE
    J Comput Aided Mol Des; 2009 Nov; 23(11):807-28. PubMed ID: 19757091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
    Ivanov AA; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2007 Jan; 25(5):740-54. PubMed ID: 17095272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site.
    Gutiérrez-de-Terán H; Centeno NB; Pastor M; Sanz F
    Proteins; 2004 Mar; 54(4):705-15. PubMed ID: 14997566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into signaling from the beta2-adrenergic receptor structure.
    Audet M; Bouvier M
    Nat Chem Biol; 2008 Jul; 4(7):397-403. PubMed ID: 18560432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding site analysis of full-length alpha1a adrenergic receptor using homology modeling and molecular docking.
    Pedretti A; Elena Silva M; Villa L; Vistoli G
    Biochem Biophys Res Commun; 2004 Jun; 319(2):493-500. PubMed ID: 15178433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
    Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
    ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.
    Evers A; Klabunde T
    J Med Chem; 2005 Feb; 48(4):1088-97. PubMed ID: 15715476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands.
    Karellas P; McNaughton M; Baker SP; Scammells PJ
    J Med Chem; 2008 Oct; 51(19):6128-37. PubMed ID: 18783211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
    Bera I; Laskar A; Ghoshal N
    J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.